Professional Documents
Culture Documents
CPM Guidant Corporation Shaping Culture Through Systems Christoper
CPM Guidant Corporation Shaping Culture Through Systems Christoper
CPM Guidant Corporation Shaping Culture Through Systems Christoper
Sales organizations
4. Western Hemisphere Sales
5. European Operations
6. Pacific Rim Sales
Guidant’s Business Unit
Cardiac Rhythm
Vascular Minimally Invasive
Management
Intervention (VI) Surgery (MIS)
(CRM)
• President : Jay • President : • President : Jay
Rac Ginger Howard Watkins
• Combination of • Combination of • Predecessor :
Cardiac Advanced Origin
Pacemakers, Cardiovascular Medsystems
Inc. and Health Systems, Inc. • Product :
Rhythm and Devices for laparoscopy
Technologies Vascular
• Product : cardiac Intervention, Inc.
pacemakers, • Product :
defibrillators, catheters
and leads
GUIDANT’S STRATEGY
Global product
innovation
Economic
Organizational partnerships with
excellence customers
worldwide
Global Product Innovation
• Family approach to speed product development
Core theme to work with for the eight strategic design teams:
Build Cost- Create a Stream
Leverage Sales Optimize Global
Effective of Novel Business
and Distribution Presence
Administration and Products
Build Competence
Leverage Influence Public
to Ensure Speed Minimize Risk of
Manufacturing Policy Important to
to Regulatory Regulatory Actions
Assets Our Business
Approval
Shareholder Value
Capital market as the ultimate judge of Guidant’s ability to
create shareholder value
2. Belief systems
communicate core company values
CC = Cost of Capital
AA = Average Assets
AVC = Average Current Liabilities
Performance Measurement
System
10% of compensation was
contingent upon increases in
this residual income measure
for Guidant
Incentive of the
performance
Global Guidant’s
business heads 60% of their compensation
(Compensation of linked to stock performance
the ten senior through stock ownership and
managers) stock options (as part of the
long term compensation)
Divisional Performance
The employees’ contribution
was invested in a diversified
fund
• FDA required:
- detailed information on the characteristic of new
medical device products and the manufacturing
process
- Guidant to inform the agency of any changes in
products, manufacturing process and sales material
Risk Management System
• A new compliance function (Chief Compliance Officer)
was created to address this important control issue
1996
Four managers evaluated whether the system s put in place
●
Next
Long term planning (a well excuted planning system required a
●